Skip to main content
Premium Trial:

Request an Annual Quote

Belgium's VIB to Use Biogazelle qPCR Data-analysis Software

Premium

BITS, the bioinformatics training and service facility of Belgium's Vlaams Instituut voor Biotechnologie, or VIB, will use Biogazelle's qbase+ software for PCR analysis, Biogazelle said this week.

Under a group license, qbase+ is now available to more than 1,000 researchers from more than 10 VIB departments.

Based on peer-reviewed geNorm and qBase technology developed by Ghent University's Jo Vandesompele and Jan Hellemans, qbase+ is qPCR data-analysis software designed for mRNA gene expression profiling and analysis, miRNA profiling and validation studies, and gene copy number analysis, among other applications.

"Qbase+ will allow us to improve the accuracy of our results and bring our qPCR-based research to a higher level," Herwig Van Marck, director of BITS, said in a statement. "The peer-reviewed software algorithms will help our researchers to annotate and process qPCR data according to international guidelines."

Van Marck added that the group can ensure data quality by using various calculations available in qbase+ for post-PCR quality control, PCR efficiency correction, normalization, inter-run calibration, and statistics.

Biogazelle, based in Zwijnaarde, Belgium, said that it will also provide training sessions and expertise to qPCR users within VIB.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.